Viswanathan Ravi

CIK 000147938638 companiesTIMONIUM, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001479386

Recent Transactions

50 trades

Conversion
Elastic N.V.$ESTC
Ordinary Shares
2018-10-10+4,155,995→ 4,155,995 total
Conversion
Elastic N.V.$ESTC
Ordinary Shares
2018-10-10+1,528,117→ 1,528,117 total
Conversion
Elastic N.V.$ESTC
Series D Convertible Preference Shares
2018-10-10−1,528,117→ 0 total
Conversion
Elastic N.V.$ESTC
Series C Convertible Preference Shares
2018-10-10−4,155,995→ 0 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-09-07$1.67/sh+12,000,000→ 12,000,000 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-09-07$1.67/sh+3,000,000→ 82,978,668 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-08-21$2.26/sh+663,716→ 18,698,038 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-07-19$2.00/sh+50,600→ 18,034,322 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-07-18$1.95/sh+200,000→ 17,983,722 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-06-28$2.10/sh+187,130→ 17,783,722 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-06-27$2.15/sh+5,295→ 17,596,592 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-30$2.15/sh+275→ 17,591,297 total
Award
ARDELYX, INC.$ARDX
Common Stock
2018-05-25$4.00/sh+416,666→ 3,082,186 total
Award
ARDELYX, INC.$ARDX
Common Stock
2018-05-25$4.00/sh+416,667→ 3,082,186 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-21$2.14/sh+32,200→ 17,591,022 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-18$2.14/sh+20,100→ 17,558,822 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-17$2.13/sh+184,179→ 17,538,722 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-05-08$2.13/sh+70,873→ 17,354,543 total
Conversion
MULESOFT, INC
Class B Common Stock
2018-05-01−12,679,970→ 0 total
Conversion
MULESOFT, INC
Class B Common Stock
2018-05-01−2,576,939→ 0 total
Conversion
MULESOFT, INC
Class A Common Stock
2018-05-01+858,978→ 858,978 total
Conversion
MULESOFT, INC
Class A Common Stock
2018-05-01+2,576,939→ 2,576,939 total
Disposition from Tender
MULESOFT, INC
Class A Common Stock
2018-05-01−858,978→ 0 total
Disposition from Tender
MULESOFT, INC
Class A Common Stock
2018-05-01−2,576,939→ 0 total
Disposition from Tender
MULESOFT, INC
Class A Common Stock
2018-05-01−12,679,970→ 0 total
Conversion
MULESOFT, INC
Class B Common Stock
2018-05-01−858,978→ 0 total
Conversion
MULESOFT, INC
Class A Common Stock
2018-05-01+12,679,970→ 12,679,970 total
Conversion
Surface Oncology, Inc.
Common Stock
2018-04-23+3,179,544→ 3,179,544 total
Conversion
Surface Oncology, Inc.
Series A Preferred Stock
2018-04-23−6,995,000→ 0 total
Purchase
Surface Oncology, Inc.
Common Stock
2018-04-23$15.00/sh+133,333→ 3,312,877 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-04-10$2.46/sh+203,200→ 17,283,670 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-04-09$2.43/sh+32,100→ 17,080,470 total
Purchase
AVEO PHARMACEUTICALS, INC.
Common Stock
2018-04-06$2.24/sh+685,676→ 17,048,370 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-03-27$1.92/sh+6,000,000→ 79,978,672 total
Purchase
Tracon Pharmaceuticals, Inc.
Common Stock
2018-03-27$2.70/sh+707,964→ 3,466,003 total
Purchase
Tracon Pharmaceuticals, Inc.
Warrant to Purchase Common Stock
2018-03-27$0.13/sh+707,964→ 707,964 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-03-26$1.90/sh+571,164→ 73,978,672 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-03-23$1.95/sh+294,090→ 73,407,508 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-03-22$1.90/sh+869,574→ 73,113,418 total
Purchase
Adaptimmune Therapeutics PLC$ADAP
Ordinary Shares with a nominal value of 0.001 GBP per share
2018-03-21$1.81/sh+104,844→ 72,243,844 total
Disposition from Tender
Cascadian Therapeutics, Inc.
Common Stock
2018-03-09−10,882,574→ 0 total
Purchase
TESARO, Inc.
Common Stock
2018-03-06$59.82/sh+3,159→ 739,516 total
Purchase
TESARO, Inc.
Common Stock
2018-03-06$59.82/sh+12,634→ 9,681,129 total
Purchase
TESARO, Inc.
Common Stock
2018-03-05$59.76/sh+4,311→ 736,357 total
Purchase
TESARO, Inc.
Common Stock
2018-03-05$58.28/sh+30,321→ 9,649,647 total
Purchase
TESARO, Inc.
Common Stock
2018-03-05$58.28/sh+7,557→ 731,646 total
Purchase
TESARO, Inc.
Common Stock
2018-03-05$59.15/sh+400→ 732,046 total
Purchase
TESARO, Inc.
Common Stock
2018-03-05$59.15/sh+1,600→ 9,651,247 total
Purchase
TESARO, Inc.
Common Stock
2018-03-05$59.76/sh+17,248→ 9,668,495 total
Purchase
TESARO, Inc.
Common Stock
2018-03-02$57.34/sh+17,859→ 9,619,326 total

Companies

Recent Filings

Address

1954 GREENSPRING DRIVE SUITE 600

TIMONIUM, MD, 21093

View on SEC.gov